Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Brain Metabolism
100%
Chemotherapy
100%
Pediatric Hodgkin Lymphoma
100%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose Uptake
44%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
33%
Brain Regions
22%
Whole-body
22%
Pediatric Patients
22%
Brainstem
11%
Parietal Cortex
11%
Cognitive Effects
11%
Clinical Remission
11%
End of Therapy
11%
Temporal Change
11%
Cognitive Dysfunction
11%
Glucose Metabolism
11%
Lymphoma
11%
Pediatric Cancer
11%
Median Time
11%
Neuromodulation
11%
Generalized Estimating Equations
11%
Anterior Cingulate Cortex
11%
Progressive Change
11%
Cancer Population
11%
Brain Positron Emission Tomography
11%
Background Potential
11%
Regional Brain Metabolism
11%
Follow-up Surveillance
11%
Deep Gray Matter nuclei
11%
Positron Emission Tomography/computed Tomography (PET/CT)
11%
Brain Data
11%
Prophylactic Intrathecal Chemotherapy
11%
Non-central Nervous System Cancer
11%
Medicine and Dentistry
Pediatrics
100%
Non-Hodgkin Lymphoma
100%
Fluorodeoxyglucose
100%
Brain Metabolism
100%
Chemotherapy
100%
Pediatrics Patient
22%
Brain Region
22%
Positron Emission Tomography-Computed Tomography
22%
Intrathecal Drug Administration
11%
Glucose Metabolism
11%
Computer Assisted Tomography
11%
Pediatric Cancer
11%
Neuromodulation
11%
Brainstem
11%
Cingulate Cortex
11%
Gray Matter
11%
Positron Emission Tomography
11%
Tomography
11%
Parietal Cortex
11%
Brain Positron Emission Tomography
11%
Nervous System Cancer
11%
Neurocognitive Side Effect
11%
Long-Term Outcome
11%
Neuroscience
Brain Metabolism
100%
Non-Hodgkin Lymphoma
100%
Chemotherapy
100%
Pediatrics
100%
Positron Emission Tomography-Computed Tomography
20%
Brain Region
20%
Metabolic Pathway
10%
Brainstem
10%
Parietal Cortex
10%
Gray Matter
10%
Intrathecal
10%
Positron Emission Tomography
10%
Neuromodulation
10%
Cingulate Cortex
10%
Brain Positron Emission Tomography
10%
Nervous System Cancer
10%
Nucleus
10%
Side Effect
10%
Glucose
10%